Jazz Pharmaceuticals schedules series of September investor sessions
Executives from Dublin-based Jazz Pharmaceuticals will engage with the financial community through a sequence of four fireside chats this September. These sessions, hosted by major investment banks, provide a platform for the biopharmaceutical company to discuss its current research pipeline and therapeutic portfolio with global investors.
The company’s leadership team is set to appear at the Wells Fargo 21st Annual Healthcare Conference on September 9, followed by the Citi 2026 Biopharma Back to School Summit on September 10. The schedule continues with the Morgan Stanley 24th Annual Global Healthcare Conference on September 15 and concludes with the Deutsche Bank Healthcare Summit on September 16.
Interested parties can access live audio webcasts for each presentation through the investor relations portal on the company’s website. Recordings of these sessions will remain available for replay for 30 days following the events. These engagements arrive as the company continues to focus on its core areas of epilepsy, oncology, and sleep disorder treatments.
Comments (0)
No comments yet. Be the first!